As detected by the RT-PCR, western blotting and IHC technologies, significant increases in IMP3 mRNA and protein levels were observed in prostate cancer tissues as compared with the normal tissues (Fig. 1a-c). This evidence concerns the gene IMP3 and prostate carcinoma.